Compare NEWP & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEWP | LYEL |
|---|---|---|
| Founded | 1972 | 2018 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 450.2M | 369.4M |
| IPO Year | N/A | 2021 |
| Metric | NEWP | LYEL |
|---|---|---|
| Price | $3.53 | $33.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $4.25 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 1.0M | 57.7K |
| Earning Date | 11-07-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $41,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.93 | $7.65 |
| 52 Week High | $3.70 | $35.16 |
| Indicator | NEWP | LYEL |
|---|---|---|
| Relative Strength Index (RSI) | 72.06 | 75.94 |
| Support Level | $2.65 | $20.59 |
| Resistance Level | $3.70 | $35.16 |
| Average True Range (ATR) | 0.24 | 2.56 |
| MACD | 0.10 | 1.05 |
| Stochastic Oscillator | 88.03 | 85.38 |
New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.